EXACT SCIENCES CORP is 5.3x more valuable than VERACYTE, INC. by market capitalization ($20.03 B vs $3.78 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCYT | EXAS |
|---|---|---|
| Market cap | $3.78 B | $20.03 B |
| US-listed rank | #1633 | #632 |
| Revenue (latest FY) | $517.14M | $3.25B |
| Net income (latest FY) | $66.40M | -$207.95M |
| Net margin | 12.8% | -6.4% |
| P/E (trailing FY) | 56.9 | - |
| SEC filings | 1,126 | 1,834 |
EXACT SCIENCES CORP is 5.3x more valuable than VERACYTE, INC. by market capitalization ($20.03 B vs $3.78 B).
In their latest fiscal years, VERACYTE, INC. reported $517.14M in revenue while EXACT SCIENCES CORP reported $3.25B.
Full pages: VERACYTE, INC. and EXACT SCIENCES CORP, or browse the full rankings.